For which age group is the adjuvanted inactivated influenza vaccine approved?

The adjuvanted inactivated influenza vaccine is specifically formulated and approved for use in older adults, particularly those aged 65 years and older. The use of adjuvants in this vaccine enhances the immune response in this population, who often have a weaker immune response to vaccines due to age-related changes in the immune system.

This targeted approach aims to improve vaccine efficacy among older adults, helping to ensure better protection against influenza, which can be more severe in this age group. In general, while other influenza vaccines may be available for a broader range of age groups, the adjuvanted formulation is distinctively approved for seniors to address their unique health needs and vulnerabilities.